2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation
- PMID: 32243306
- PMCID: PMC7147416
- DOI: 10.1097/LGT.0000000000000528
2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation
Abstract
Objective: To manage cervical screening abnormalities, the 2019 ASCCP management consensus guidelines will recommend clinical action on the basis of risk of cervical precancer and cancer. This article details the methods used to estimate risk, to determine the risk-based management, and to validate that the risk-based recommendations are of general use in different settings.
Methods: Based on 1.5 million patients undergoing triennial cervical screening by cotesting at the Kaiser Permanente Northern California from 2003 to 2017, we estimated risk profiles for different clinical scenarios and combinations of past and current human papillomavirus and cytology test results. We validated the recommended management by comparing with the estimated risks in several external data sources.
Results: Risk and management tables are presented separately by Egemen et al. and Demarco et al. Risk-based management derived from the Kaiser Permanente Northern California largely agreed with the management implied from the estimated risks of the other data sources.
Conclusions: The new risk-based guidelines present management of abnormal cervical screening results. By describing the steps used to develop these guidelines, the methods presented in this article can provide a basis for future extensions of the risk-based guidelines.
Conflict of interest statement
R.S.G. reports that he was an ASCCP consultant for the guideline and a DSMB consultant for Ikonosys. The other authors have declared they have no conflicts of interest.
Similar articles
-
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529. J Low Genit Tract Dis. 2020. PMID: 32243308 Free PMC article.
-
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.J Low Genit Tract Dis. 2020 Apr;24(2):144-147. doi: 10.1097/LGT.0000000000000530. J Low Genit Tract Dis. 2020. PMID: 32243309 Free PMC article.
-
Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.J Natl Cancer Inst. 2018 May 1;110(5):501-508. doi: 10.1093/jnci/djx225. J Natl Cancer Inst. 2018. PMID: 29145648 Free PMC article.
-
Cervical cancer screening: evidence behind the guidelines.Am J Obstet Gynecol. 2016 Apr;214(4):438-443. doi: 10.1016/j.ajog.2015.10.147. Epub 2015 Oct 28. Am J Obstet Gynecol. 2016. PMID: 26519782 Review.
-
Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.Surg Pathol Clin. 2018 Sep;11(3):589-599. doi: 10.1016/j.path.2018.05.001. Surg Pathol Clin. 2018. PMID: 30190142 Review.
Cited by
-
Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data.J Cancer. 2020 Aug 25;11(20):6157-6167. doi: 10.7150/jca.48357. eCollection 2020. J Cancer. 2020. PMID: 32922555 Free PMC article.
-
HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions.Vaccines (Basel). 2020 May 23;8(2):245. doi: 10.3390/vaccines8020245. Vaccines (Basel). 2020. PMID: 32456136 Free PMC article.
-
Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2.Diagnostics (Basel). 2021 Sep 7;11(9):1634. doi: 10.3390/diagnostics11091634. Diagnostics (Basel). 2021. PMID: 34573975 Free PMC article.
-
BD SurePath Direct to Slide (DTS) cervical cytology: Migrating the benefits of liquid-based cytology to low-resource settings.Am J Clin Pathol. 2024 Jun 24;162(6):559-69. doi: 10.1093/ajcp/aqae068. Online ahead of print. Am J Clin Pathol. 2024. PMID: 38913880 Free PMC article.
-
DYNAMIC RISK PREDICTION FOR CERVICAL PRECANCER SCREENING WITH CONTINUOUS AND BINARY LONGITUDINAL BIOMARKERS.Ann Appl Stat. 2024 Mar;18(1):246-265. doi: 10.1214/23-aoas1788. Epub 2024 Jan 31. Ann Appl Stat. 2024. PMID: 40881043 Free PMC article.
References
-
- Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17(5 suppl 1):S1–27. - PubMed
-
- Castle PE, Xie X, Xue X, et al. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Prev Med 2019;118:44–50. - PubMed